Baker-Blais creates educational programs for information-seeking consumers and patients with specific chronic conditions. Our programs are textbook 1:1 marketing in which readability, credibility, rapport and dialogue are required.

Despite the industry’s efforts that focus on physician-detailing, CMEs, journal ads, sampling and the role of the pharmacist — consumers are playing an ever-increasing role in deciding their therapy.

We’ve learned that even when patients educate themselves they are rarely prepared to have a meaningful discussion with their physician. Does the patient understand his condition and therapy choices? Does he give the physician all the necessary information? Is it the right information? What are the patient’s expectations for therapy? Will she follow her therapy as prescribed? Will she take the actions and make the life-style changes that will maximize its benefits and promote adherence?

Our EduCare™ programs address these issues and this is precisely Baker-Blais’ area of expertise.

If you have reviewed our DTC Regulations 101 section, it should be clear that certain types of Direct-To-Consumer information (DTCI) programs are admissible.

In fact, Health Canada encourages consumer health information that is fair, balanced, objective, educational and informational — called Direct-To-Consumer Information (DTCI). To distinguish between DTCI and Direct-To-Consumer Advertising (DTCA), Health Canada publishes Official Guidelines to assist healthcare and pre-clearance agencies.

Both our EduCare™ and traditional programs follow the Health Canada Guidelines for DTCI.

A distinct benefit to our clients is our pharmaceutical program library. We are enrolled in over 200 patients programs in Canada, the US and the UK. These programs include market expansion, retention, compliance and public awareness. The learnings from these programs are incorporated into our EduCare™ programs, which inspire, motivate and inform consumers.